Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-08

Clinical Trial Update: The Effect of Cannabis on Dementia Related Agitation and Aggression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effect of cannabis on agitation and aggression related to dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabis (Cannabis)

Snippet

Sponsor: TO Pharmaceuticals | Conditions: Agitation Related to Dementia | Phase 2 | Status: COMPLETED